These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31270853)

  • 1. Safety of intralesional injection of lauromacrogol combined with triamcinolone for infantile hemangiomas.
    Chai Y; Zhou Z; Song J; Lv R; Xu G; Bi J; Li X; Li Z; Huo R
    J Dermatol; 2019 Sep; 46(9):770-776. PubMed ID: 31270853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aesthetic outcome of intralesional injection of lauromacrogol as a single-agent treatment for uncomplicated infantile hemangiomas: A long-term follow-up study.
    Lin PF; Chen FC; Chen JY; Jiang CH
    J Dermatol; 2020 Oct; 47(10):1119-1125. PubMed ID: 32643255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intralesional corticosteroid application for hemangiomas.
    Emir S; Gürlek Gökçebay D; Demirel F; Tunç B
    Turk J Med Sci; 2015; 45(2):335-8. PubMed ID: 26084124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and safety between oral propranolol combined with and without intralesional injection of lauromacrogol for infantile hemangioma.
    Ma F; Liu X; Wang C; Duan H; Zhou K; Hu F
    Front Pediatr; 2024; 12():1361105. PubMed ID: 38989270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases.
    Chantharatanapiboon W
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S90-6. PubMed ID: 19253502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol.
    Pandey V; Tiwari P; Sharma SP; Kumar R; Singh OP
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):908-912. PubMed ID: 29665992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 100 infants.
    Couto JA; Greene AK
    J Plast Reconstr Aesthet Surg; 2014 Nov; 67(11):1469-74. PubMed ID: 25104131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas.
    Alsmman AH; Mounir A
    Clin Ophthalmol; 2017; 11():2177-2181. PubMed ID: 29263646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
    Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
    Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intralesional corticosteroid and propranolol treatment of periorbital infantile hemangiomas: an outcome study of 61 cases.
    Hoornweg MJ; Saeed P; Tanck MW; Hage JJ; Coumou AD; Van Der Horst CM
    Eur J Ophthalmol; 2014; 24(6):940-7. PubMed ID: 24729139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local steroid therapy in cutaneous hemangiomas.
    Gangopadhyay AN; Sharma SP; Gopal SC; Gupta DK; Panjawani K; Sinha JK
    Indian Pediatr; 1996 Jan; 33(1):31-3. PubMed ID: 8772948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional steroid injection for proliferative parotid hemangiomas.
    Buckmiller LM; Francis CL; Glade RS
    Int J Pediatr Otorhinolaryngol; 2008 Jan; 72(1):81-7. PubMed ID: 18054392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Endoscopic Sclerotherapy Using Lauromacrogol Injection for Laryngopharyngeal Hemangioma.
    Qu H; Lei X; Hu L; Yin X; Du X; Zhang L; Sun C
    Ear Nose Throat J; 2021 Nov; 100(9):662-666. PubMed ID: 34551625
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of infantile hemangioma by intralesional injection of propranolol combined with compound betamethasone.
    Shao RZ; Zhao DH; Li J
    Eur Rev Med Pharmacol Sci; 2016; 20(4):751-5. PubMed ID: 26957280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional steroid in the era of propranolol for infantile hemangioma-Do we need it?
    Pandey A; Srivastava A; Pant N; Singh S; Rawat J
    J Plast Reconstr Aesthet Surg; 2023 Feb; 77():117-122. PubMed ID: 36566639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subsequent therapy for infantile hemangiomas after discontinuation of oral propranolol].
    Tai MZ; Liu XJ; Qin ZP; Ge CX; Li KL; Chen T
    Shanghai Kou Qiang Yi Xue; 2015 Dec; 24(6):716-20. PubMed ID: 27063125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional injection of bevacizumab versus triamcinolone acetonide in infantile hemangioma.
    Sabry HH; Sorour NE; Akl EM
    J Dermatolog Treat; 2020 May; 31(3):279-284. PubMed ID: 30835573
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response.
    Düzenli Kar Y; Özdemir ZC; Acu B; Bör Ö
    Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.